Effect of mortality from COVID-19 on inpatient outcomes

Matthew C Phillips1, Laura Sarff1, Josh Banerjee1

  • 1Los Angeles County + University of Southern California (LAC + USC) Medical Center, Los Angeles, California, USA.

Journal of Medical Virology
|September 13, 2021
PubMed

Insights

Hospital mortality from coronavirus disease 2019 (COVID-19) declined to under 10% by June 2020. However, overall inpatient mortality has increased, particularly for elderly patients and those needing intubation.

Area of Science:

  • Healthcare Analytics
  • Epidemiology
  • Critical Care Medicine

Background:

  • Initial encounters with coronavirus disease 2019 (COVID-19) presented limited therapeutic options, leading to high mortality rates.
  • By summer 2020, national trends and single-center studies indicated a decline in COVID-19-specific patient mortality.

Purpose of the Study:

  • To assess the impact of COVID-19 on overall hospital-based mortality using a large, multi-center dataset.
  • To analyze trends in inpatient mortality from January 2017 through December 2020, encompassing the initial phase of the pandemic.

Main Methods:

  • Utilized the Vizient Clinical Data Base, analyzing over 32 million hospital admissions from approximately 600 hospitals, including 130 academic medical centers.
  • Examined outcomes data from January 2017 to December 2020 to track mortality trends before and during the COVID-19 pandemic.

Main Results:

  • Mortality from COVID-19 decreased significantly to below 10% nationally by June 2020 and remained stable.
  • Despite the decline in COVID-19-specific deaths, overall inpatient, all-cause mortality increased post-pandemic onset.
  • Inpatient mortality saw a marked rise in elderly patients and those requiring intubation for respiratory failure.

Conclusions:

  • While COVID-19 mortality improved, its overall contribution has elevated hospital mortality rates, especially for critically ill patients requiring mechanical ventilation.
  • The pandemic's broader impact on hospital care necessitates continued monitoring of inpatient mortality trends beyond COVID-19-specific outcomes.

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
159
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
526
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
309
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
508